Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?-Reference-Cited by-同舟云学术

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?

Published:2010-11 Issue:11 Volume:34 Page:1437-1441
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Costa Dolors,Valera Sandra,Carrió Ana,Arias Amparo,Muñoz Concha,Rozman María,Belkaid Mohamed,Coutinho Rita,Nomdedeu Benet,Campo Elias

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues,2008

2. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes;Solé;Hematologica,2005

3. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients;Haase;Blood,2007

4. Molecular analysis of the 5q− chromosome;Nagarajan;Leuk Lymphoma,1995

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis of genotype and phenotype reveals clonal evolution and cytogenetically driven disruption of myeloid cell maturation in myelodysplastic syndromes;Cytometry Part B: Clinical Cytometry;2021-11-13

2. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype;Clinical Lymphoma Myeloma and Leukemia;2021-01

3. Comparative assessment of conventional chromosomal analysis and fluorescence in situ hybridization in the evaluation of suspected myelodysplastic syndromes: A single institution experience;Avicenna Journal of Medicine;2019-04

4. Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?;Leukemia & Lymphoma;2018-09-06

5. Evaluation of the Utility of Bone Marrow Morphology and Ancillary Studies in Pediatric Patients Under Surveillance for Myelodysplastic Syndrome;American Journal of Clinical Pathology;2018-04-05